Loading component...

Updated blood lead reference value for children

Dec. 2021Important Notices

The Centers for Disease Control and Prevention (CDC) recently updated its blood lead reference value (BLRV) from 5 µg/dL to 3.5 µg/dL in response to a recommendation by the Lead Exposure Prevention and Advisory Committee (LEPAC).

The BLRV aims to identify children with higher levels of lead in their blood compared to most children, based on the 97.5th percentile of the blood lead level (BLL) distribution in U.S. children ages 1 to 5 years.1 However, the CDC states that there is no safe BLL in children and that even low levels of lead in blood can affect learning and academic achievement and have permanent effects. It is critical for providers to partner with parents and caregivers to help prevent exposure and lower a child’s lead level, if necessary. To connect members with case management and for environmental lead investigation support, please contact the UPMC Pediatric Care Management Department. You can email a referral to pedscasemanagement@upmc.edu or call 1-866-778-6073 and select “pediatrics.”

Learn more
For more information about BLL in children, visit cdc.gov/nceh/lead/prevention/blood-lead-levels.htm. You can also view the UPMC Health Plan Lead Screening Provider Tip Sheet.

Source
1Centers for Disease Control and Prevention. CDC updates blood lead reference value for children. Last reviewed Oct. 28, 2021. Accessed Nov. 2, 2021. cdc.gov/media/releases/2021/p1028-blood-lead.html


Recent Announcements

Voluntary nationwide recall: Alcohol Pads (Cardinal – March)

Cardinal Health is recalling multiple lots of Webcol™ Large Alcohol Prep Pads (70% isopropyl alcohol). Alcohol prep pads are used for external cleansing of the skin.
Mar. 2026Pharmacy Updates

Medical device correction: Omnipod 5 (Insulet – March 2026)

Insulet Corporation has announced a medical device correction for certain Omnipod 5 pods. These pods are wearable devices that are used to deliver insulin.
Mar. 2026Pharmacy Updates

Asymptomatic Severe Coronary Disease: Detection to Decisions. Do We Know The Proper Management?

In this new CME course, Krishna V. Tummalapalli, MD, interventional cardiologist, UPMC Heart and Vascular Institute, discusses how to explain the importance of early detection of coronary artery disease, as well as how to describe how early identification can reduce future cardiovascular events and identify appropriate first line medical therapy strategies for patients with asymptomatic stable ischemic heart disease.
Mar. 2026Education/Webinars

Loading component...